BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27775802)

  • 1. Expression of lncRNA HULC in cervical cancer and its correlation with tumor progression and patient survival.
    Wang YF; Zhang S; Li XQ; Wang Y
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3987-3991. PubMed ID: 27775802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of long non-coding RNA LET inhibits carcinogenesis of cervical cancer.
    Jiang S; Wang HL; Yang J
    Int J Clin Exp Pathol; 2015; 8(1):806-11. PubMed ID: 25755778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Expression Levels of Long Non-Coding RNA, Loc554202, Are Predictive of Poor Prognosis in Cervical Cancer.
    Chen J; Zhu J
    Tohoku J Exp Med; 2017 Nov; 243(3):165-172. PubMed ID: 29129878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer.
    Jin C; Shi W; Wang F; Shen X; Qi J; Cong H; Yuan J; Shi L; Zhu B; Luo X; Zhang Y; Ju S
    Oncotarget; 2016 Aug; 7(32):51763-51772. PubMed ID: 27322075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
    Cao S; Liu W; Li F; Zhao W; Qin C
    Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer.
    Peng W; Gao W; Feng J
    Med Oncol; 2014 Dec; 31(12):346. PubMed ID: 25412939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
    Chen X; Liu L; Zhu W
    Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA CCHE1 overexpression predicts a poor prognosis for cervical cancer.
    Chen Y; Wang CX; Sun XX; Wang C; Liu TF; Wang DJ
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):479-483. PubMed ID: 28239824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer.
    Huang L; Liao LM; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M
    Arch Gynecol Obstet; 2014 Oct; 290(4):717-23. PubMed ID: 24748337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.
    Sun XH; Yang LB; Geng XL; Wang R; Zhang ZC
    Int J Clin Exp Pathol; 2015; 8(3):2994-3000. PubMed ID: 26045809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical important dysregulation of long non-coding RNA CCHE1 and HULC in carcinogenesis of cervical cancer.
    Naghashi N; Ghorbian S
    Mol Biol Rep; 2019 Oct; 46(5):5419-5424. PubMed ID: 31364021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA activated by transforming growth factor-β promotes cancer development and is a prognostic marker in cervical cancer.
    Cao W; Peng T; Zhou Y
    J Cancer Res Ther; 2017; 13(5):801-806. PubMed ID: 29237907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of LncRNA PANDAR predicts poor prognosis and promotes cell proliferation in cervical cancer.
    Huang HW; Xie H; Ma X; Zhao F; Gao Y
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4529-4535. PubMed ID: 29131264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
    Li M; Li BY; Xia H; Jiang LL
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients.
    Uzan VR; Lengert Av; Boldrini É; Penna V; Scapulatempo-Neto C; Scrideli CA; Filho AP; Cavalcante CE; de Oliveira CZ; Lopes LF; Vidal DO
    PLoS One; 2016; 11(6):e0156774. PubMed ID: 27253450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA FEZF1-AS1 is up-regulated and associated with poor prognosis in patients with cervical cancer.
    Zhang HH; Li AH
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3357-3362. PubMed ID: 29917186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
    Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
    Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
    Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
    Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
    Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.